Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer

NCT00521781 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Sponsor decision

Conditions

Prostatic Neoplasms

Interventions

DRUG: Abraxane
DRUG: Leuprolide
DRUG: Bicalutamide

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]